CLINICAL_TRIALS
research
· 2025-08-22
Clinical Trial Update: Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome
Summary
Expanded access/compassionate use program for Rugonersen in Angelman Syndrome is available.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oak Hill Bio Ltd | Conditions: Angelman Syndrome | Status: AVAILABLE